Adam Adler, Ph.D.

Dr. Adler has more than 15 years of research and laboratory management experience, including deep expertise in antibody discovery. At GigaGen, he leads laboratory research operations and is responsible for the research and development of GigaGen’s product pipeline in oncology, infectious disease, and immune deficiency. He has used his expertise in cutting-edge technologies including microfluidics, protein engineering, and genomics to create GigaGen’s immune analysis and drug discovery technologies that have enabled rapid pipeline development. Prior to GigaGen, Dr. Adler held research management roles at LakePharma (now Curia), where he was responsible for all internal and external projects including developing new antibody sequence analysis tools, and at Genentech where he worked to identify novel oncogenes and validate cancer drug targets. Dr. Adler has authored over 35 research publications in leading journals, is an inventor on over 45 US and international patents, and holds a B.A. in Biological Sciences from Northwestern University and a Ph.D. in Cancer Biology from Stanford University School of Medicine.